Browse Category

Solutions - Page 2

New Medical Solutions curates credible advances that solve real problems in healthcare—faster diagnosis, safer procedures, better monitoring, smoother coordination, and fairer access.

Lonza hands off capsule business to investment firm Lone Star in $3B deal

Under the deal with Lone Star Funds, Lonza maintains a 40% stake in its capsules and health ingredients business while receiving 1.7 billion Swiss francs ($2.2 billion) upfront.

March 6, 2026

News·Solutions

Sanofi strikes deal with Brazil’s EMS to sell generics manufacturer Medley

Sanofi has agreed to sell its Medley generics unit in Brazil to leading local drugmaker EMS, according to an announcement from international law firm Mayer Brown. An EMS exec said the deal

March 6, 2026

News·Solutions

Taiwan earmarks $755M for multi-year drug supply resilience program

The three-pronged plan to strengthen domestic drug supply will be supported by an investment of 24 billion new Taiwan dollars ($755 million), President Lai Ching-te said.

March 6, 2026

News·Solutions

Forma Life Sciences launches with oral solid dose focus, joining class of new CDMOs

Forma Life Sciences, which inherited BioDuro’s California operations earlier this year, officially launched as a CDMO with a focus on oral solid dosage drugs this week.

March 5, 2026

News·Solutions

BioDuro enters Taiwan joint venture, adding commercial API plant to production network

BioDuro, headquartered in California, has set up a new joint venture with Taiwan drug ingredients manufacturer, Cenra API Solutions. The new enterprise will see Cenra’s commercial-scale facility in Taipei folded into BioDuro’s

March 4, 2026

News·Solutions

CDMO Quotient extends Ipsen supply pact for rare disease drug Sohonos

Quotient Sciences, a CDMO that specializes in “niche and smaller volume” drugs, has extended a deal with Ipsen to manufacture Sohonos (palovarotene) capsules. Sohonos is currently the only medication approved by the

March 2, 2026

News·Solutions

Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation

MTI Viewpoint Insights shared by industry relative to healthcare and the advancement of medical technology. Rene Zoelfl is Global Industry Advisor Life Science, supports life science companies in their transformation towards greater agility

March 1, 2026

Solutions

Merck to wind down Gardasil production at N.C. plant, lay off 150-plus

In a Worker Adjustment and Retraining Notification Act alert filed this week, Merck revealed that it is laying off 147 staffers at a vaccine manufacturing plant in Durham. The cuts are a

February 27, 2026

News·Solutions

Decision Criteria for Technology Commercialization of Medical Devices in 2026

The successful commercialization of innovative medical technologies remains a cornerstone of advancing healthcare delivery and patient outcomes. The journey from a novel concept to a market-ready product is fraught with complexity, requiring

February 26, 2026

Solutions

Viatris to cut 10% of workforce in 3-year overhaul, discloses fire at India plant

Viatris’ three-year reorganization will affect staffers in a range of functions including the company’s commercial teams, R&D, medical affairs and manufacturing. Besides the layoffs, the drugmaker also reported a fire in India.

February 26, 2026

News·Solutions

Previous 1 2 3 4 … 14 Next

Go toTop